Navigation Links
Europe Hemostasis Testing Market Reviewed in Insightful VPG Report Now Available at

London, UK (PRWEB) August 14, 2013

Hemostasis testing practice is poised to witness considerable changes in the upcoming years. The factors influencing this change include the increasing cost containment pressures in the developed countries along with the ongoing technological advancements in molecular diagnostics, chromagenic substrates, immunoassays, monoclonal antibodies, computer and laboratory automation.

The demand for novel specific and sensitive hemostasis markers on automated instrumentation is expected to increase substantially in the offing. Hemostasis testing is also predicted to become more standardised, thus, bringing new opportunities for quality control services and products.

Insightful research report “Hemostasis Testing: Granular Analysis of European Market Supplier Shares and Forecasts for 40 Tests France, Germany, Italy, Spain, UK” worked out by Venture Planning Group (VPG) has been recently published by Market Publishers Ltd.

Report Details:

Title: Hemostasis Testing: Granular Analysis of European Market Supplier Shares and Forecasts for 40 Tests France, Germany, Italy, Spain, UK
Published: July, 2013
Price:    US$ 12,800.00

The report provides a comprehensive overview of the hemostasis testing markets in France, Germany, Italy, Spain and the UK. The study uncovers essential information on the industry performance, identifies and evaluates major market opportunities, presents an insightful market segmentation analysis. The report delves into the competitive landscape, offers vital details on the leading companies and contains data on the sales and shares of the major hemostasis testing instrument and reagent suppliers. In addition, the report discloses test forecasts for the 40 major procedures by market segment and by country.

Market segments covered in the study include: hospitals, commercial/private laboratories, physician offices and ambulatory care centers.

Reasons to Buy:

  •     The report offers an insightful analysis of the five country hemostasis testing markets in Europe (France, Germany, Italy, Spain and the UK).
  •     Vital data on the industry performance helps to get a comprehensive understanding of the current market situation.
  •     The research study allows current market players and potential market entrants to identify and evaluate the emerging market opportunities and turn them into the maximum benefit.
  •     Future forecast is essential for the planning of the effective business, marketing and new product development strategies.
  •     Details on the competitive landscape and the leading companies assist in gaining a competitive advantage in the market and in choosing the potential business partners.
More in-demand research reports by the publisher can be found at VPG page.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe
2. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
3. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
4. Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union
5. European Multiple Sclerosis Market in Dire Need of Increased Disease Awareness and Treatment Options, Cautions Frost & Sullivan
6. Islet Sciences Announces DiaKine Therapeutics Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection
7. Chronic Hepatic Diseases Generate High Costs to Europe
8. Tackling the European market of nanoimprint lithography
9. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
10. Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
11. Global Markets for Enzymes in Industrial Applications -- Focus on Europe
Post Your Comments:
(Date:11/24/2015)... -- Cepheid (NASDAQ: CPHD ) today announced that ... and invited investors to participate via webcast. ... 1, 2015 at 11.00 a.m. Eastern Time --> ... 1, 2015 at 11.00 a.m. Eastern Time --> ... NY      Tuesday, December 1, 2015 at 11.00 ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... on behalf of the Toronto Stock Exchange, confirms that ... are no corporate developments that would cause the recent ... --> --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical ...
(Date:11/24/2015)... , November 24, 2015 SHPG ) announced ... in the Piper Jaffray 27 th Annual Healthcare Conference in ... 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ... Financial Officer, will participate in the Piper Jaffray 27 th ... NY on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 ...
(Date:11/24/2015)... ... 24, 2015 , ... In harsh industrial processes, the safety ... sensors can represent a weak spot where leaking process media is a possible ... housings , which are designed to tolerate extreme process conditions. They combine rugged ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015 About signature ... helps to identify and verify the identity of ... as the secure and accurate method of authentication ... particular individual because each individual,s signature is highly ... when dynamic signature of an individual is compared ...
(Date:11/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), the leading ... into the automotive market with a comprehensive and dedicated ... consumer electronics human interface innovation. Synaptics, industry-leading touch controllers, ... automotive industry and will be implemented in numerous locations ... , Japan , and ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
Breaking Biology News(10 mins):